These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 14323801)

  • 21. [THROMBOLYTIC THERAPY].
    ISIDORI A
    Rass Fisiopatol Clin Ter; 1964; 36():219-27. PubMed ID: 14174161
    [No Abstract]   [Full Text] [Related]  

  • 22. [INJURIES OF THE SPLEEN AND ANTICOAGULANTS. PARTIAL SUCCESS RUPTURE TREATED BY SUTURING].
    ARNULF G
    Lyon Chir; 1963 Jul; 59():616-8. PubMed ID: 14090867
    [No Abstract]   [Full Text] [Related]  

  • 23. [PATHOLOGICAL CHANGES OF BLOOD COAGULATION IN THROMBOTIC DISEASES].
    KOLLER F
    Klin Monbl Augenheilkd; 1964 Mar; 144():161-8. PubMed ID: 14176393
    [No Abstract]   [Full Text] [Related]  

  • 24. [THROMBOLYSIS CAUSED BY PLASMINOGEN ACTIVATION AND BY DIRECT PROTEOLYSIS].
    SCHMIDT HW
    Arzneimittelforschung; 1965 Feb; 15():132-5. PubMed ID: 14263132
    [No Abstract]   [Full Text] [Related]  

  • 25. THE PREVENTION OF ARTERIAL THROMBOSIS BY FIBRINOLYTIC ACTIVATION WITH UROKINASE: AN EXPERIMENTAL STUDY.
    BRADY MP; O'CONNELL L; FITZGERALD PA
    Ir J Med Sci; 1965 Jun; 474():261-71. PubMed ID: 14326625
    [No Abstract]   [Full Text] [Related]  

  • 26. RATIONALE OF THROMBOLYTIC THERAPY IN ARTERIAL OCCLUSIVE DISEASE.
    NAHUM LH
    Conn Med; 1964 Sep; 28():638-41. PubMed ID: 14201312
    [No Abstract]   [Full Text] [Related]  

  • 27. THE PRESENT STATUS OF FIBRINOLYTIC THERAPY.
    CLIFFTON EE
    Angiology; 1963 Nov; 14():533-41. PubMed ID: 14075024
    [No Abstract]   [Full Text] [Related]  

  • 28. Fibrinolysis. II. Evaluation of enzymatic thrombolysis: Experiments with plasmin preparations in arterial, venous thrombosis.
    NAHUM LH; KLINE D; FISHBEIN R
    Conn Med; 1960 Mar; 24():139-46. PubMed ID: 14425837
    [No Abstract]   [Full Text] [Related]  

  • 29. THROMBOLYTIC THERAPY.
    DOUGLAS AS; MCNICOL GP
    Proc R Soc Med; 1964 Jul; 57(7):609-14. PubMed ID: 14178954
    [No Abstract]   [Full Text] [Related]  

  • 30. Mechanism of clot lysis by streptokinase and effects of epsilon-aminocaproic acid.
    ABLONDI FB; DE RENZO EC
    Proc Soc Exp Biol Med; 1959; 102():717-9. PubMed ID: 13791495
    [No Abstract]   [Full Text] [Related]  

  • 31. IMMUNOHISTOCHEMICAL STUDY OF THROMBOLYTIC MECHANISMS.
    BACK N; HIRAMOTO R; AMBRUS JL
    Blood; 1965 Jun; 25():1028-36. PubMed ID: 14294764
    [No Abstract]   [Full Text] [Related]  

  • 32. EFFECTS OF FIBRINOLYTIC AGENTS AND HEPARIN ON INTRAVASCULAR CLOT LYSIS.
    LEWIS JH; KERBER CW; WILSON JH
    Am J Physiol; 1964 Nov; 207():1044-8. PubMed ID: 14237447
    [No Abstract]   [Full Text] [Related]  

  • 33. [Distreptase in the treatment of postoperative blood clots following extrapleural or extrafascial pneumothorax].
    BOCHINSKI K; DWORAK W; DYBICKI J
    Gruzlica (1926); 1955 Dec; 23(12):883-8. PubMed ID: 13318449
    [No Abstract]   [Full Text] [Related]  

  • 34. STUDIES ON THE RESISTANCE OF RED BLOOD CELLS TO THE HEMOLYTIC ACTION OF DISTREPTASE (STREPTOKINASE + STREPTODORNASE).
    HANKIEWICZ J
    Arch Immunol Ther Exp (Warsz); 1964; 12():534-41. PubMed ID: 14247378
    [No Abstract]   [Full Text] [Related]  

  • 35. RADIOACTIVE (I-125) HUMAN PLASMA CLOTS FOR ASSAY OF THROMBOLYTIC ACTIVITY.
    HUME M
    J Lab Clin Med; 1964 Apr; 63():699-702. PubMed ID: 14155458
    [No Abstract]   [Full Text] [Related]  

  • 36. EFFECT OF ANTICOAGULANT, FIBRINOLYTIC, AND ANTIFIBRINOLYTIC AGENTS ON EXPERIMENTAL HYALINE MEMBRANES.
    FUJIKURA T
    Am J Obstet Gynecol; 1964 Dec; 90():850-3. PubMed ID: 14241506
    [No Abstract]   [Full Text] [Related]  

  • 37. The utilization of streptokinase-streptodornase in a patient with hemopneumothorax and a patient with postpneumonectomy sanguineous coagulum.
    READ CT; BERRY FB
    J Thorac Surg; 1950 Sep; 20(3):384-92. PubMed ID: 14774890
    [No Abstract]   [Full Text] [Related]  

  • 38. [CLINICAL TRIAL OF COMBINED USE OF VARIDASE BUCCAL AND ANTICOAGULANTS].
    SUDA E
    Rinsho Ganka; 1963 Dec; 17():1380-6. PubMed ID: 14102189
    [No Abstract]   [Full Text] [Related]  

  • 39. Oral hemorrhage secondary to the use of varidase buccal tablets (streptokinase-streptodornase) in conjunction with anticoagulant therapy with hedulin (phenindione); (case report).
    BENSHOFF AM
    W V Med J; 1959 Nov; 55():397. PubMed ID: 13798990
    [No Abstract]   [Full Text] [Related]  

  • 40. [THERAPY OF THROMBOEMBOLISM. 2].
    GSELL O; STRAESSLE B
    Med Klin; 1963 Nov; 58():1869-72. PubMed ID: 14111019
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.